Nanoparticulate RNA delivery systems in cancer

Abstract

Background: Drug delivery system is a common practice in cancer treatment. RNA interference-mediated post-transcriptional gene silencing holds promise as an approach to knockdown in the expression of target genes responsible for cancer cell growth and metastasis. RNA interference (RNAi) can be achieved by delivering small interfering RNA (siRNA) and short hairpin RNA (shRNA) to target cells. Since neither interfering RNAs can be delivered in naked form due to poor stability, an efficient delivery system is required that protects, guides, and delivers the siRNA and shRNA to target cells as part of cancer therapy (chemotherapy). Recent findings: In this review, a discussion is presented about the different types of drug delivery system used to deliver siRNA and shRNA, together with an overview of the potential benefits associated with this sophisticated biomolecular therapy. Improved understanding of the different approaches used in nanoparticle (NP) fabrication, along with an enhanced appreciation of the biochemical properties of siRNA/ shRNA, will assist in developing improved drug delivery strategies in basic and clinical research. Conclusion: These novel delivery techniques are able to solve the problems that form an inevitable part of delivering genes in more efficient manner and as part of more effective treatment protocols. The present review concludes that the nanoparticulate RNA delivery system has great possibility for cancer treatment along with several other proposed methods. Several NPs or nanocarriers are already in use, but the methods proposed here could fulfill the missing gap in cancer research. It is the future technology, which unravels the mystery of resolving genomic diseases that is, especially genomic instability and its signaling cascades.

Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review

“…The 22-nucleotide (nt) small interfering RNA (siRNA) can inhibit the expression of messenger RNA (mRNA) ( Sheng et al, 2020 ). However, siRNA has the disadvantage of poor stability, making naked siRNA delivery unfeasible ( Sharma et al, 2020 ). Exosomes have significant advantages as a carrier in terms of siRNA protection, guidance, and delivery.…”

Advances in Pulmonary Drug Delivery Targeting Microbial Biofilms in Respiratory Diseases

“…Chitosan also possesses antibacterial and anti-biofilm properties against S. aureus, E. coli, and S. typhimurium [96]. Chitosan NPs are formulated through ion gelation with TPP (polyanionic sodium triphosphate) [97].…”

Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment

“…7 They have also been widely used for the delivery of hydrophilic molecules like small organic molecule as well as large biomolecules like siRNA, mRNA and miRNA. [8][9][10][11] The nanocarriers for anticancer drug delivery are broadly classified in four main categories, i.e., lipid-based, polymerbased, inorganic, and hybrid nanocarriers. Each class of nanocarriers consists of multiple subclasses, among them some of the most common subclasses are presented in Fig.…”